Check whether you may qualify for the Medicare GLP-1 Bridge ($50 a month through 2027).
This is an interactive tool. No signup required, and we don't store your answers.
How to use this tool
Answer the questions below. The tool will calculate your result and show how the result changes based on inputs. The math behind each result is documented in the methodology section at the bottom.
Interactive tool
The interactive version of this tool is being rolled out across the site. While that ships, see the related guides below.
Try the Match Quiz →Methodology behind this tool
The math behind this tool is sourced from published trial data, FDA labels, and pharmacy list pricing. We update inputs monthly. Where ranges are wide (insurance pricing, for example), we show low/mid/high estimates rather than a single number.
Related tools
NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.